LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Phibro Animal Health Corp

Fechado

SetorSaúde

51.23 -0.37

Visão Geral

Variação de preço das ações

24h

Atual

Mín

50.7

Máximo

52.13

Indicadores-chave

By Trading Economics

Rendimento

932K

27M

Vendas

10M

374M

P/E

Médio do Setor

23.462

121.746

EPS

0.87

Rendimento de Dividendos

0.9

Margem de lucro

7.344

Funcionários

2,475

EBITDA

-12M

50M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

-6.79% downside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.90%

2.26%

Próximos Ganhos

6 de mai. de 2026

Próxima data de dividendos

25 de mar. de 2026

Próxima data de ex-dividendo

4 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

403M

2.1B

Abertura anterior

51.6

Fecho anterior

51.23

Sentimento de Notícias

By Acuity

45%

55%

138 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Phibro Animal Health Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de fev. de 2026, 23:47 UTC

Ações em Alta

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 de fev. de 2026, 22:59 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Grab Holdings to Buy U.S.-Based Stash Financial

11 de fev. de 2026, 23:54 UTC

Ganhos

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 de fev. de 2026, 23:50 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

11 de fev. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 de fev. de 2026, 23:49 UTC

Ganhos

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 de fev. de 2026, 23:45 UTC

Ganhos

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 de fev. de 2026, 23:42 UTC

Ganhos

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 de fev. de 2026, 23:41 UTC

Ganhos

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 de fev. de 2026, 23:40 UTC

Ganhos

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 de fev. de 2026, 23:35 UTC

Conversa de Mercado

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 de fev. de 2026, 23:18 UTC

Conversa de Mercado

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 de fev. de 2026, 23:14 UTC

Conversa de Mercado

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 de fev. de 2026, 22:59 UTC

Ganhos

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 de fev. de 2026, 22:59 UTC

Ganhos

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 de fev. de 2026, 22:59 UTC

Ganhos

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 de fev. de 2026, 22:58 UTC

Ganhos

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 de fev. de 2026, 22:57 UTC

Ganhos

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 de fev. de 2026, 22:54 UTC

Ganhos

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 de fev. de 2026, 22:53 UTC

Ganhos

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 de fev. de 2026, 22:47 UTC

Ganhos

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 de fev. de 2026, 22:47 UTC

Ganhos

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 de fev. de 2026, 22:23 UTC

Ganhos

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 de fev. de 2026, 22:22 UTC

Ganhos

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 de fev. de 2026, 22:22 UTC

Ganhos

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 de fev. de 2026, 22:19 UTC

Ganhos

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 de fev. de 2026, 22:18 UTC

Ganhos

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 de fev. de 2026, 22:18 UTC

Ganhos

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 de fev. de 2026, 22:18 UTC

Ganhos

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 de fev. de 2026, 22:16 UTC

Ganhos

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Comparação entre Pares

Variação de preço

Phibro Animal Health Corp Previsão

Preço-alvo

By TipRanks

-6.79% parte inferior

Previsão para 12 meses

Média 48.33 USD  -6.79%

Máximo 58 USD

Mínimo 38 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Phibro Animal Health Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

3 ratings

1

Comprar

1

Manter

1

Vender

Pontuação Técnica

By Trading Central

17 / N/ASuporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

138 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat